• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Multiple Myeloma: Big Survival Gains From Novel Agents In The Real World

  • — 28 Jun, 2010
Evangelos Terpos
Evangelos Terpos, University of Athens
AudioMedica News
AudioMedica News
Multiple Myeloma: Big Survival Gains From Novel Agents In The Real World
Multiple Myeloma: Big Survival Gains From Novel Agents In The Real World
00:00 /
RSS Feed
Share
Link
Embed
Evangelos Terpos

Evangelos Terpos, University of Athens

Big improvements in survival among patients with multiple myeloma were reported at the European Hematology Association annual congress in Barcelona by Greek researchers looking at the past decade of therapy with the novel agents: thalidomide, lenalidomide and bortezomib in the “real world” setting. Professor Evangelos Terpos from the University of Athens discusses his groups findings on bone metabolism under novel agent therapy and assesses the impact of these drugs on survival among patients in Greece.



LISTEN

[audio:https://www.audiomedica.com/podcasting/oncology/100628EvangelosTerposPODCAST.mp3]

You may also like...

  • Audio Journal of Oncology in Advance – March 1st, 2007 Audio Journal of Oncology in Advance – March 1st, 2007 2 Mar, 2007
  • Andrew Loblaw Low risk localized prostate cancer: no harm from waiting! 16 Mar, 2013
  • David Hayes Gene expression and molecular pathways guide head and neck cancer therapies 24 Apr, 2013
  • BRCA1/2 Ovarian Cancer—Three Years Disease Free with First-Line Olaparib BRCA1/2 Ovarian Cancer—Three Years Disease Free with First-Line Olaparib 1 Nov, 2018
  • Previous story Rituximab Maintenance Cuts Follicular Lymphoma Recurrence Risk In Half — Phase III PRIMA Study Results
  • Next story Plasmodium Ovale Malaria Parasite: Found To Be Two Species
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic Lymphocytic…
    • Microbiome Diversity Key To Survival After Allogeneic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • New Front Line Standard for Older Patients with Chronic…
    • CT Screening Cuts Lung Cancer Deaths 24 Per Cent—Second…
  • Home
  • Oncology
  • Multiple Myeloma: Big Survival Gains From Novel Agents In The Real World

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.